Oxis Turbuhaler (Formoterol Fumarate Dihydrate)

Formoterol fumarate dihydrate, the active ingredient in Oxis Turbuhaler, is a long‑acting β2‑adrenergic agonist (LABA) presented as an inhalation powder for oral inhalation use. It provides bronchodilation for patients with chronic obstructive pulmonary disease and asthma. GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Formoterol fumarate dihydrate is a bronchodilator that acts on the airway smooth muscle to improve airflow in obstructive lung diseases.

- Asthma: improves symptom control and reduces the frequency of exacerbations. - Chronic obstructive pulmonary disease (COPD): enhances lung function and decreases rescue‑inhaler use. - Exercise‑induced bronchoconstriction: prevents narrowing of the airways during physical activity.

Formoterol may cause a range of adverse reactions, most of which are mild to moderate in intensity.

Common Side Effects: - Tremor - Headache - Throat irritation - Cough - Nasal congestion - Palpitations

Serious or Rare Side Effects: - Paradoxical bronchospasm - Severe tachycardia - Hypokalemia - Hypersensitivity reactions including anaphylaxis - Cardiovascular events such of the risk of serious effects —   y

When using Oxis Turbuhaler   g   ewline   ewline    bsp  ...  ewline ... etc…  ewline  ewline ... ... ... ... ...